| Intrinsic Valuation of: VRSK | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 7 | Market Cap | $21B | |||||
| 2021 | - | - (-) | P/E Ratio | 25 | Total Asset | $6B | |||||
| 2022 | $784M | - (-) | Net Income | $908M | Total Debt | $3B | |||||
| 2023 | $831M | 5.9% (-1.4%) | EBITDA | $2B | Total Liab | $6B | |||||
| 2024 | $920M | 10.8% (3.1%) | Opr Margin | 43.74 | Debt/Equity | 10.37 | |||||
| 2025 | $1B | 29.5% (21.5%) | PreTax Margin | 38.17 | BV/Share | -15 | |||||
| 5Y Average FCF | $932M | 10.5% (7.7%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.03% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (10.5%) | ||||||||||
| 2026 | $1B | MBG Intrinsic Value | $59 | ||||||||
| 2027 | $1B | ||||||||||
| 2028 | $1B | ||||||||||
| 2029 | $2B | ||||||||||
| 2030 | $2B | ||||||||||
| 2031 | $2B | ||||||||||
| Terminal Value | $36B | Net Worth/Share | $2 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $31B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $2B | $229 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $3B | WACC | 6.5% | 217 | 236 | 261 | 293 | 336 | |||
| Equity Value | $30B | 7.1% | 191 | 206 | 224 | 247 | 276 | ||||
| Shares Outstanding | 131,021,840 | 7.8% | 170 | 182 | 196 | 213 | 233 | ||||
| 8.4% | 154 | 163 | 174 | 187 | 202 | ||||||
| DCF Intrinsic Value | $229 | 9.0% | 140 | 148 | 156 | 166 | 178 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||